Truist Downgrades PTC Therapeutics (PTCT) to Hold; near-term headwinds, KOL sees low likelihood of Translarn CHMP opinion reversal
Tweet Send to a Friend
(Updated - October 5, 2023 4:43 PM EDT)
Truist Securities analyst Robyn Karnauskas downgraded PTC Therapeutics (NASDAQ: PTCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Robyn Karnauskas downgraded PTC Therapeutics (NASDAQ: PTCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
